Related Experiment Video

Updated: Feb 3, 2026

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus
07:23

Using a Whole-mount Immunohistochemical Method to Study the Innervation of the Biliary Tract in Suncus murinus

Published on: June 15, 2017

7.2K

A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation

Suneel Deepak Kamath1, Xiaoqi Lin2, Aparna Kalyan3,4

  • 1Department of Medicine, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA suneel.kamath@northwestern.edu.

The Oncologist
|October 25, 2018
PubMed

Insights

Next-generation sequencing identified an IDH1 mutation in a patient initially diagnosed with duodenal adenocarcinoma. This genomic finding led to a revised diagnosis of biliary tract cancer, highlighting sequencing

Area of Science:

  • Oncology
  • Genomics
  • Cancer Diagnostics

Background:

  • Next-generation sequencing (NGS) is established for identifying targetable genomic alterations in circulating tumor DNA (ctDNA) and formalin-fixed paraffin-embedded (FFPE) tissues.
  • Genomic profiling offers potential as a diagnostic tool when traditional methods like immunohistochemistry are inconclusive.
  • Identifying unique genomic signatures across various histologies is crucial for advancing diagnostic capabilities.

Observation:

  • A 73-year-old male presented with a duodenal mass and peritoneal carcinomatosis, initially diagnosed as metastatic duodenal adenocarcinoma.
  • Genomic profiling of ctDNA and FFPE tissue revealed an IDH1 mutation, uncommon in duodenal adenocarcinoma but characteristic of biliary tract cancers (BTCs).
  • This molecular finding prompted a re-biopsy, leading to a revised diagnosis of pancreaticobiliary adenocarcinoma.

Findings:

  • The case highlights a novel application of NGS as a diagnostic aid, successfully altering a primary cancer diagnosis.
  • Isocitrate dehydrogenase (IDH) mutations are rare in most solid tumors but highly specific for biliary tract cancers (BTCs) among gastrointestinal malignancies.
  • The molecular specificity of IDH mutations to certain histologies is clinically significant.

Implications:

  • NGS can refine cancer diagnoses, leading to more appropriate and effective therapeutic strategies.
  • The specificity of IDH mutations underscores the importance of comprehensive genomic profiling in complex cases.
  • Ongoing research into IDH inhibitors for advanced and metastatic BTCs shows promising early results, offering new treatment avenues.

More Related Videos

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.8K
Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery07:36

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

2.4K

Related Concept Videos

Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.3K